Literature DB >> 32445376

Expression of Daratumumab and Elotuzumab Migration by Capillary Electrophoresis Relative to Transferrin Improves Precision of Their Identification.

Forest Huls1, Lee Schroeder2, David F Keren2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32445376     DOI: 10.1093/jalm/jfz008

Source DB:  PubMed          Journal:  J Appl Lab Med        ISSN: 2475-7241


× No keyword cloud information.
  2 in total

1.  Characterization of Casirivimab Plus Imdevimab, Sotrovimab, and Bamlanivimab Plus Etesevimab-Derived Interference in Serum Protein Electrophoresis and Immunofixation Electrophoresis.

Authors:  Ashley Rose Scholl; Dimitrios Korentzelos; Taylor E Forns; Ethan K Brenneman; Matthew Kelm; Michael Datto; Sarah E Wheeler; Eric D Carlsen
Journal:  J Appl Lab Med       Date:  2022-08-22

2.  Use of a Daratumumab-Specific Immunofixation Assay to Assess Possible Immunotherapy Interference at a Major Cancer Center: Our Experience and Recommendations.

Authors:  Daniel C Kirchhoff; Kazunori Murata; Katie L Thoren
Journal:  J Appl Lab Med       Date:  2021-11-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.